Intrapulmonary delivery of polypeptide growth factors and cytokines
US6402733B1 · kind B1 · utility
8Cited by
16References
46Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 19, 2000 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Apr 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polypeptides selected from the group of growth factors and cytokines are administered by intrapulmonary inhalation. Disclosed are novel compositions and devices for effecting the intrapulmonary administration of these polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.